IM Cannabis

IM Cannabis produces and distributes medical cannabis. Its products include products for patients and offer research and development of new genetic strains. Oren Shuster and Rafael Gabay founded IM cannabis in Glil Yam, Tel Aviv in 2010.

<div>IM Cannabis Corp. (CSE: IMCC) (Nasdaq: IMCC) is an international cannabis company specializing in providing premium medical cannabis products to patients in Israel and Germany. The company operates a transnational ecosystem powered by a data-driven approach and a globally sourced product supply chain. IM Cannabis leverages a commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients in Israel, utilizing proprietary data and patient insights. In Israel, the company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs to ensure safe delivery and quality control throughout the supply chain. In Germany, IM Cannabis distributes medical cannabis products to pharmacies through its subsidiary Adjupharm GmbH.</div>

Israel’s medical cannabis patient growth slows as industry awaits major reform

After exiting Canada, Israel’s IM Cannabis reorganizes business

IMC welcomes new Israeli cannabis regulations which are about to change significantly, facilitating access for many new patients

Israel’s new rules might spur growth in medical cannabis industry

How Israel became the world leader in medical marijuana

Social and cultural shifts accompanied by changes in laws spark new opportunities

Cannabis

IM Cannabis announces $1.61M private placement offering

<div>
 
 IM Cannabis Corp. (CSE: IMCC) (Nasdaq: IMCC) is an international cannabis company specializing in providing premium medical cannabis products to patients in Israel and Germany. The company operates a transnational ecosystem powered by a data-driven approach and a globally sourced product supply chain. IM Cannabis leverages a commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients in Israel, utilizing proprietary data and patient insights. In Israel, the company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs to ensure safe delivery and quality control throughout the supply chain. In Germany, IM Cannabis distributes medical cannabis products to pharmacies through its subsidiary Adjupharm GmbH.
 
 
 
 
 IM Cannabis recently exited operations in Canada to concentrate on sustainable and profitable growth in the Israeli and German markets. The company cultivates an unwavering commitment to responsible growth and compliance within the strictest regulatory environments. With the anticipated medical cannabis regulatory reform in Israel, scheduled for implementation in December 2023 but delayed due to the ongoing conflict, IM Cannabis expects significant growth in patient numbers and potential export opportunities to Europe through EU-GMP certification.
 
 
 
</div>

Cresco Labs is a vertically integrated multistate cannabis operator with a focus on delivering consistent quality products across its portfolio of branded offerings. The company cultivates, processes, and distributes a diverse range of cannabis products, including flower, vapes, concentrates, edibles, and pre-rolls. Cresco Labs operates under multiple brands, such as Cresco, FloraCal Farms, Good News, Wonder Wellness Co., Mindy's Edibles, and Remedi, catering to various consumer preferences and occasions.
Cresco's cultivation practices involve rigorous phenotype hunting and small-batch cultivation to ensure premium quality. Their products are meticulously hand-trimmed and expertly cared for throughout the process. The company's brand portfolio aims to provide consistent, reliable, and enjoyable cannabis experiences for consumers, whether they are familiar with the plant or new to it.
As of December 2023, Cresco Labs operated in numerous states across the US, with 21 production facilities and 49 dispensaries under the Sunnyside retail banner. The company has implemented operational changes to improve its environmental impact and formed partnerships, such as with Temple University, to explore the potential healing properties of cannabis.
In February 2023, Cresco Labs expanded its retail presence by opening a new Sunnyside dispensary in Daytona Beach, Florida, marking its 23rd location in the state and 58th nationwide. The company reported generating revenue of approximately USD 822 million for the full year 2021.

Cresco Labs

<div>
 
 TerrAscend is a leading North American cannabis operator with vertically integrated operations in California, Maryland, Michigan, New Jersey, and Pennsylvania, as well as retail operations in Canada. The company focuses on growing high-quality cannabis, promoting its health benefits, and offering a diverse range of products tailored to the needs of medical patients and adult-use consumers. TerrAscend utilizes advanced cultivation techniques, innovative cannabis cultivars, and strategic technology investments to produce premium cannabis products.
 
 
 
 
 In March 2022, TerrAscend completed the acquisition of Gage Growth Corp., a prominent cannabis brand and operator, in a deal valued at over USD 545 million. This strategic acquisition aimed to create a differentiated and compelling player in the North American cannabis market, combining TerrAscend's proven cultivation and manufacturing expertise with Gage's top-selling brands and exceptional retail experiences.
 
 
 
 
 As of January 2023, TerrAscend operated 32 dispensaries nationwide under its award-winning retail concepts, The Apothecarium and Gage. The company's portfolio includes several synergistic businesses and brands, such as Gage Cannabis, Ilera healthcare, Kind Tree, Prism, State Flower, Valhalla Confections, and Arise Bioscience Inc. In May 2023, TerrAscend strengthened its balance sheet by selling a facility in Canada for CADUSD 19.7 million, using the proceeds to pay down existing debt.
 
</div>

TerrAscend

Holistic Industries is a multistate cannabis company that specializes in cultivating, manufacturing, and distributing a diverse range of premium cannabis products. Their portfolio includes Liberty Cannabis flower strains, meticulously grown and sustainably cultivated to offer an exceptional experience across indica, sativa, and hybrid varieties. Holistic Industries also produces Strane vape cartridges, crafted with CO2-extracted cannabis oil and all-natural terpenes for a smooth and flavorful vaping experience. Additionally, they offer Strane concentrates in various forms, such as shatter, wax, and live resin, catering to consumers seeking potency and purity. The company's product line further encompasses Holistic Remedies, a collection of topicals and tinctures, as well as elixirs and edibles, including cannabis-infused sparkling waters and chocolates, providing precise dosing and delicious flavors.
Holistic Industries places a strong emphasis on quality control, subjecting their products to rigorous testing processes to ensure they are free from contaminants, pesticides, and consistently meet high standards. The company collaborates with scientists, medical professionals, and researchers to develop cutting-edge cannabis formulations and products. Furthermore, Holistic Industries prioritizes sustainable practices, demonstrating a commitment to environmental responsibility.
In December 2023, Holistic Industries launched the Garcia Hand Picked cannabis brand, a collaboration with the family of Grateful Dead guitarist Jerry Garcia, after years of sampling countless strains to find one worthy of his name.

Holistic Industries

<div>
 
 Flower One is a Nevada-based cannabis cultivator and producer focused on the state's lucrative cannabis market. The company operates a 455,000 square-foot greenhouse and production facility, the largest in Nevada. As of June 2019, Flower One commenced continuous harvest operations, capable of producing 140,000 lbs (62,500 kg) of dry flower annually from over 100,000 plants across eight flower zones per crop cycle. Additionally, Flower One owns North Las Vegas Organics, a 25,000 square-foot indoor cultivation facility with nine grow rooms that can cultivate 4,500 plants per cycle.
 
 
 
 
 Flower One produces a diverse range of cannabis products, including flower, full-spectrum oils, distillates, pre-rolls, concentrates, edibles, and topicals for various brands. In October 2018, the company acquired NLV Organics, a Las Vegas-based cannabis cultivation business, for USD 27 million, expanding its footprint in Nevada's rapidly growing cannabis industry. As of June 2022, Flower One appointed Tim Shoemake as its new Chief Operating Officer, leveraging his over 25 years of experience in global agriculture and food and beverage manufacturing. Flower One trades on the Canadian Securities Exchange under the ticker symbol &quot;FONE&quot;.
 
 
 
</div>

Flower One

Grassroots Cannabis is a vertically integrated multi-state cannabis operator based in Illinois. The company specializes in the cultivation, processing, and retail distribution of medical and recreational cannabis products. Grassroots operates over 20 dispensaries under brands like Herbology, Greenhouse, and Windy City Cannabis across six states, including Illinois, Maryland, Ohio, and Pennsylvania.
The company takes pride in its cultivation process, which involves cloning from mother plants, vegetative growth, flowering, pre-harvest flushing, harvesting, drying, and curing to ensure high-quality cannabis flower, concentrates, vapes, and edibles. Grassroots' product offerings encompass a wide range of strains, both indica and sativa, as well as hybrids. Notable strains include Bubba Diagonal, White OG, Ghost Rider, and Candyland, among others.
In July 2019, Curaleaf, a Massachusetts-based cannabis company, announced plans to acquire Grassroots for USD 875 million in stock and cash. The acquisition expanded Curaleaf's presence from 12 states to 19, adding key markets like Illinois and Pennsylvania to its portfolio. Upon completion of the deal, the combined entity would have 131 dispensary licenses, 68 operational locations, 20 cultivation sites, and 26 processing facilities.

Grassroots Cannabis

Companies that specialize in growing and refining cannabis.

Companies that distribute and sell cannabis and cannabis-related products.

Companies that extract cannabinoids to create cannabis-related medication or edibles.

Companies that carry out medical consultations to prescribe cannabis.

Companies that either provide consultations, educate, or carry out testing of cannabis products.

Some startups employ sustainable farming practices when cultivating cannabis

IM Cannabis

Sources

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless